---
title: "Chlorothiazide - Hypertensive Disorder"
sidebar: mydoc_sidebar
permalink: db00880-mesh-d006973-1.html
toc: false 
---


Path ID: `DB00880_MESH_D006973_1`
{% include image.html url="images/db00880-mesh-d006973-1.png" file="db00880-mesh-d006973-1.png" alt="db00880-mesh-d006973-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D002740">MESH:D002740 </a> | chlorothiazide | Drug |
| <a href="https://identifiers.org/UniProt:P55017">UniProt:P55017 </a> | Solute carrier family 12 member 3 | Protein |
| <a href="https://identifiers.org/GO:0070294">GO:0070294 </a> | renal sodium ion absorption | BiologicalProcess |
| <a href="https://identifiers.org/GO:0003092">GO:0003092 </a> | renal water retention | BiologicalProcess |
| <a href="https://identifiers.org/HP:0033533">HP:0033533 </a> | Increased cardiac output | PhenotypicFeature |
| <a href="https://identifiers.org/UniProt:Q12791">UniProt:Q12791 </a> | Calcium-activated potassium channel subunit alpha-1 | Protein |
| <a href="https://identifiers.org/UniProt:P00918">UniProt:P00918 </a> | Carbonic anhydrase 2 | Protein |
| <a href="https://identifiers.org/GO:0060087">GO:0060087 </a> | relaxation of vascular associated smooth muscle | BiologicalProcess |
| <a href="https://identifiers.org/GO:0038166">GO:0038166 </a> | angiotensin-activated signaling pathway | BiologicalProcess |
| <a href="https://identifiers.org/GO:0042310">GO:0042310 </a> | vasoconstriction | BiologicalProcess |
| <a href="https://identifiers.org/HP:0032263">HP:0032263 </a> | Increased blood pressure | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D006973">MESH:D006973 </a> | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Chlorothiazide | DECREASES ACTIVITY OF | Solute Carrier Family 12 Member 3 |
| Solute Carrier Family 12 Member 3 | POSITIVELY REGULATES | Renal Sodium Ion Absorption |
| Renal Sodium Ion Absorption | POSITIVELY CORRELATED WITH | Renal Water Retention |
| Renal Water Retention | POSITIVELY CORRELATED WITH | Increased Cardiac Output |
| Increased Cardiac Output | POSITIVELY CORRELATED WITH | Increased Blood Pressure |
| Chlorothiazide | DECREASES ACTIVITY OF | Carbonic Anhydrase 2 |
| Carbonic Anhydrase 2 | POSITIVELY REGULATES | Angiotensin-Activated Signaling Pathway |
| Angiotensin-Activated Signaling Pathway | POSITIVELY CORRELATED WITH | Vasoconstriction |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Increased Blood Pressure |
| Chlorothiazide | POSITIVELY REGULATES | Calcium-Activated Potassium Channel Subunit Alpha-1 |
| Calcium-Activated Potassium Channel Subunit Alpha-1 | POSITIVELY REGULATES | Relaxation Of Vascular Associated Smooth Muscle |
| Relaxation Of Vascular Associated Smooth Muscle | NEGATIVELY CORRELATED WITH | Increased Blood Pressure |
| Increased Blood Pressure | MANIFESTATION OF | Hypertensive Disorder |
|---------|-----------|---------|

Comment: The hypotensive effects of chlorothiazide and other thiazides are not necessarily due to their diuretic activity (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904515/#S1title). The exact mechanism is yet not fully understood.

Reference: 
  - [https://go.drugbank.com/drugs/DB00880#BE0000322](https://go.drugbank.com/drugs/DB00880#BE0000322)
  - [https://go.drugbank.com/drugs/DB00880#BE0000419](https://go.drugbank.com/drugs/DB00880#BE0000419)
  - [https://en.wikipedia.org/wiki/Category:Carbonic_anhydrase_inhibitors](https://en.wikipedia.org/wiki/Category:Carbonic_anhydrase_inhibitors)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/2720#section=Mechanism-of-Action](https://pubchem.ncbi.nlm.nih.gov/compound/2720#section=Mechanism-of-Action)
